Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.
about
Liver resection for intermediate hepatocellular carcinomaApplication of radiotherapy for hepatocellular carcinoma in current clinical practice guidelinesPrognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People's Republic of China.Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patientsSignificance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer stagingThe promise of metabolic phenotyping in gastroenterology and hepatology.Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System.TNM Staging of Colorectal Cancer Should be Reconsidered According to Weighting of the T Stage: Verification Based on a 25-Year Follow-Up.Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experienceEconomic burden of hepatitis C in Egypt: the future impact of highly effective therapies.Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma.Staging systems for hepatocellular carcinoma: Current status and future perspectivesThe prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma.Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma.The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients.Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.Immunohistochemical and Biochemical Expression Patterns of TTF-1, RAGE, GLUT-1 and SOX2 in HCV-Associated Hepatocellular CarcinomasUpregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma.Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014).Aggressive Therapeutic Strategies Improve the Survival of Hepatocellular Carcinoma Patients with Performance Status 1 or 2: A Propensity Score Analysis
P2860
Q26748756-C91D5B58-3FDD-4D79-BE9B-C47D4F67995BQ28076314-311546AE-2552-4753-AD2E-B1E9579A2439Q33769497-EC09A023-C941-4B5F-866B-9DC516C3FCFAQ33786041-C71DCA35-22D4-47DC-9634-121A0BE9E7E5Q35594262-DD55427D-6952-47C9-A18B-807FF9DCA2B8Q35594282-5054538C-C1C8-456B-8D62-F17D31E0718BQ35701279-72E647F1-9EFD-4BB3-9338-9709B0034731Q36153539-FB3C83F1-2C50-4A26-9420-0DE8074E65C1Q36580973-8F206DEC-06B6-4B1A-BF07-B79575FB78D9Q36741673-3F36AFBC-48DD-41E9-A753-0122B730E699Q37279353-63116AE1-C321-4425-9E53-A86450F25C75Q38282463-FD8E5423-C961-4018-97C6-EA467D179B54Q38408876-F177386E-1CBF-4738-8DB9-AD4F81F62561Q41736718-BFCCE9CE-81AA-425A-9806-525C54A67BE1Q47142272-2286A4E6-BD4F-4329-A411-F943C7B71988Q48029235-02C69B1A-73D4-4011-BE8B-300C51D4C7A9Q49545298-CA89E705-6C61-44A0-BADA-3B3DA5645F7CQ49648449-01582E99-522C-43F4-8F30-EBD13C6708B3Q52655170-15D975E5-F3E8-492B-9EDB-FB62FE444195Q52699066-AB264D9F-4FFD-40D1-B639-800748747619Q58576192-30CB4473-C10A-4EFF-8CC9-99C806D97178
P2860
Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparing staging systems for ...... tocellular carcinoma in Egypt.
@ast
Comparing staging systems for ...... tocellular carcinoma in Egypt.
@en
type
label
Comparing staging systems for ...... tocellular carcinoma in Egypt.
@ast
Comparing staging systems for ...... tocellular carcinoma in Egypt.
@en
prefLabel
Comparing staging systems for ...... tocellular carcinoma in Egypt.
@ast
Comparing staging systems for ...... tocellular carcinoma in Egypt.
@en
P2860
P1433
P1476
Comparing staging systems for ...... tocellular carcinoma in Egypt.
@en
P2093
Mohamed Saad Hashim
P2860
P304
P356
10.1371/JOURNAL.PONE.0090929
P407
P577
2014-03-06T00:00:00Z